Compare IDAI & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IDAI | COCH |
|---|---|---|
| Founded | 2016 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Blank Checks |
| Sector | Technology | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.9M | 24.4M |
| IPO Year | N/A | N/A |
| Metric | IDAI | COCH |
|---|---|---|
| Price | $4.22 | $0.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $12.00 | $9.50 |
| AVG Volume (30 Days) | 132.4K | ★ 181.3K |
| Earning Date | 11-14-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,727,824.00 | $208,000.00 |
| Revenue This Year | $3.46 | N/A |
| Revenue Next Year | $219.85 | $29.53 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 72.57 | N/A |
| 52 Week Low | $1.43 | $0.64 |
| 52 Week High | $8.96 | $1.91 |
| Indicator | IDAI | COCH |
|---|---|---|
| Relative Strength Index (RSI) | 58.83 | 43.46 |
| Support Level | $3.29 | $0.66 |
| Resistance Level | $3.78 | $0.75 |
| Average True Range (ATR) | 0.30 | 0.06 |
| MACD | 0.06 | -0.00 |
| Stochastic Oscillator | 96.17 | 25.68 |
T Stamp Inc develops and markets identity authentication software solutions for enterprise partners and peer-to-peer markets. The company is engaged in developing proprietary artificial intelligence-powered solutions; researching and leveraging biometric science, cryptography, and data mining to deliver insightful identity & trust predictions while identifying and defending against fraudulent identity attacks, protecting sensitive user information, and extending the reach of digital services through accessibility. The artificial intelligence-powered solutions segment generates revenue principally from software licenses, professional services, and recurring Software-as-a-Service ("SaaS") revenue.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.